IL3RA and acute myeloid leukemia: The administration of a single dose of anti-CD123 CAR-T cells to animals increased their survival compared to the control group, and resulted in the elimination of leukemic cells, including initially CD123dim AML populations, which may be due to the upregulation of CD123 on blasts as the disease progressed.